Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

Higher performance, slimmer cancer probe is three times more sensitive

Endomagnetics : 31 May, 2014  (New Product)
Endomagnetics has developed a new, higher performance probe for its SentiMag instrument. The slimmer probe is only 18mm in diameter and has been designed in response to demand for minimal surgical invasiveness, yet boasts a sensitivity more than three times higher than the current probe and improved surgical performance. It also offers greater robustness and better handling characteristics.
Higher performance, slimmer cancer probe is three times more sensitive

Dr Quentin Harmer, who led the development of the next generation probe, said: “Producing a slimmer probe came with design challenges as reducing the probe diameter reduces sensitivity, but we are really proud to have exceeded our design brief.  Not only did we achieve the target dimensions, we actually improved sensitivity and surgical performance while maintaining the simplicity for which the SentiMag® instrument is known”.


 


Endomagnetics developed the SentiMag probe and Sienna+ tracer as a system to locate lymph nodes as part of cancer staging procedures, and it has been validated as equivalent to the standard-of-care in ten clinical studies and trials with over 1500 patients across the EU since 2012. The system improves on the standard-of-care by increasing the availability, cost and convenience of lymph node localisation.


 


Concurrent with the launch of the new SentiMag probe, Harmer has been promoted to Chief Technology Officer. Dr Eric Mayes, CEO commented: “The development and delivery of this new probe enhances our product pipeline and IP portfolio, and develops our regulatory engagement with the FDA”.


 

Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo